Loading...
Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer
Colorectal cancer (CRC) is the third most common cancer worldwide. Even if 5‐fluorouracil (5‐FU) is used as the first‐line chemotherapeutic drug, responsiveness is only 20‐30%. Acquired resistance to 5‐FU contributes to both poor patient prognosis and relapse, emphasizing the need to identify biomar...
Na minha lista:
| Udgivet i: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7810928/ https://ncbi.nlm.nih.gov/pubmed/33325631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15752 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|